It wasn’t long ago that Morgan Stanley urged pharmaceutical companies to “Exit Research and Create Value”, but the reality today is more complicated.
We firmly believe that an excellent internal R&D organisation has the potential to create better products faster, rather than leaving R&D to others.
To turn this into a reality, pharmaceutical companies need to actively manage R&D to create real, tangible value. But where should you start?
In this white paper, we discuss the five key dimensions that drive R&D productivity:
- Dynamic Product Strategy
- Deep Commercial Insight
- Sound Commercial Model
- Strong Product Leaderships
- Fit-For-Purpose Governance
Managing R&D to create value is not as quick or simple as “exiting research to create value”.
But it is certainly a more powerful way to create fantastic medicines that will benefit patients and sustain the future of a pharmaceutical company.
Download the full white paper via the button above.